MORGAN STANLEY – Vertex Pharmaceuticals Incorporated Transaction History
MORGAN STANLEY portfolio value:
$560.99M
portfolio value
MORGAN STANLEY quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +6.04% | 110.32K shares | 46.10M | $289.54 | 1.93M |
| Q2 2022 | share | Increase | +121.25% | 1.00M shares | 299.37M | $281.79 | 1.82M |
| Q1 2022 | share | Decrease | -14.84% | -143.95K shares | 2.55M | $260.97 | 825.84K |
| Q4 2021 | share | Decrease | -6.97% | -72.70K shares | 23.87M | $222.45 | 969.80K |
| Q3 2021 | share | Decrease | -14.64% | -178.81K shares | -57.15M | $181.39 | 1.04M |
| Q2 2021 | share | Increase | +36.40% | 325.94K shares | 53.85M | $201.63 | 1.22M |
| Q1 2021 | share | Decrease | -2.45% | -22.46K shares | -24.51M | $214.89 | 895.38K |
| Q4 2020 | share | Increase | +18.66% | 144.32K shares | 6.43M | $236.34 | 917.84K |
| Q3 2020 | share | Increase | +12.28% | 84.60K shares | 10.49M | $272.12 | 773.52K |
| Q2 2020 | share | Increase | +1.99% | 13.42K shares | 39.26M | $290.31 | 688.91K |
| Q1 2020 | share | Decrease | -12.34% | -95.04K shares | -7.97M | $237.95 | 675.49K |
| Q4 2019 | share | Increase | +36.18% | 204.72K shares | 72.84M | $218.95 | 770.54K |
| Q3 2019 | share | Increase | +3.10% | 17.02K shares | -4.77M | $169.42 | 565.81K |
| Q2 2019 | share | Increase | +7.34% | 37.50K shares | 6.58M | $183.38 | 548.79K |
| Q1 2019 | share | Decrease | -31.57% | -235.84K shares | -29.75M | $183.95 | 511.29K |
| Q4 2018 | share | Increase | +8.16% | 56.37K shares | -9.32M | $165.71 | 747.14K |
| Q3 2018 | share | Increase | +11.14% | 69.24K shares | 27.50M | $192.74 | 690.76K |
| Q2 2018 | share | Decrease | -21.59% | -171.16K shares | -23.55M | $169.96 | 621.52K |
| Q1 2018 | share | Decrease | -38.84% | -503.38K shares | -65.03M | $162.98 | 792.68K |
| Q4 2017 | share | Increase | +55.36% | 461.81K shares | 67.38M | $149.86 | 1.29M |
| Q3 2017 | share | Decrease | -49.88% | -830.15K shares | -87.65M | $152.04 | 834.25K |
| Q2 2017 | share | Increase | +175.38% | 1.06M shares | 148.39M | $128.87 | 1.66M |
| Q1 2017 | share | Increase | +117.09% | 325.99K shares | 45.58M | $109.35 | 604.40K |
| Q4 2016 | share | Decrease | -61.64% | -447.41K shares | -42.79M | $73.67 | 278.40K |
| Q3 2016 | share | Increase | +269.26% | 529.26K shares | 46.39M | $87.21 | 725.82K |
| Q2 2016 | share | Decrease | -45.26% | -162.54K shares | -11.63M | $86.02 | 196.55K |
| Q1 2016 | share | Increase | +15.90% | 49.27K shares | -10.44M | $79.49 | 359.10K |